Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aventis scientists present new tubulin polymerization inhibitors

Nov. 21, 2002

Phase I/II trial initiated for LE-SN-38

Nov. 20, 2002

Preclinical and early clinical data discussed for OSI-7836 in Frankfurt

Nov. 20, 2002

FDA approves SuperGen's NDA to market Mitozytrex

Nov. 20, 2002

D-63153, a new GnRH antagonist as a candidate for sex steroid-dependent diseases

Nov. 20, 2002

Bay-43-9006 scheduled to enter phase III in 2003

Nov. 20, 2002

FDA approves CMC amendment for ONYX-015

Nov. 20, 2002

Coley and GSK enter license agreement for cancer vaccines

Nov. 20, 2002

Kosan and NCI to clinically develop geldanamycin analogues

Nov. 20, 2002

ENMD-0995 trial for patients with multiple myeloma under way

Nov. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...